Lv5
890 积分 2025-06-23 加入
Comparative review of novel model‐assisted designs for phase I clinical trials
10天前
已完结
Bayesian optimal interval designs for phase I clinical trials
17天前
已完结
Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling
19天前
已完结
Physiologically based pharmacokinetic modeling to characterize enterohepatic recirculation and predict food effect on the pharmacokinetics of hyzetimibe
1个月前
已完结
Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3
1个月前
已完结
Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trial
1个月前
已关闭
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study
2个月前
已完结
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer
2个月前
已完结
Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study
2个月前
已完结
皖公网安备34019202002308
